TriSalus Life Sciences Warrant
TLSIW
6 hedge funds and large institutions have $1.11M invested in TriSalus Life Sciences Warrant in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 3 closing their positions.
3% more capital invested
Capital invested by funds: $1.08M → $1.11M (+$29.8K)
0.19% less ownership
Funds ownership: 3.2% → 3.01% (-0.19%)
25% less funds holding
Funds holding: 8 → 6 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$227 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GL
1
Graypoint LLC
Albany,
New York
| $960K | – | – | – |
|
|
VI
2
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $103K | – | – | – |
|
|
ACM
3
Alpha Capital Management
Austin,
Texas
| $25.8K | – | – | – |
|
|
FVWA
4
Foster Victor Wealth Advisors
Greenville,
South Carolina
| $14.6K | -$7.39K | -5,727 | -31% |
|
|
WAM
5
Wolverine Asset Management
Chicago,
Illinois
| $10.6K | -$6.67K | -5,165 | -37% |
|
|
6
Bank of America
Charlotte,
North Carolina
| $204 | +$227 | +176 | New |
|
|
HF
7
HRT Financial
New York
| – | -$23K | -21,253 | Closed |
|
|
CS
8
Clear Street
New York
| – | -$110 | -100 | Closed |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$46 | -42 | Closed |
|
TLSIW Hedge Fund Activity: Q1 2025 in Review
6 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2025, worth a combined $1.11M — up 2.7% from $1.08M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of TLSIW and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Bank of America, opening a new position worth an estimated $227. The largest seller was HRT Financial, exiting entirely with an estimated $23K sold.
- 6 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2025, down from 8 in Q4 2024.
- Funds reported $1.11M of TriSalus Life Sciences Warrant stock for Q1 2025, up 2.7% quarter-over-quarter.
- 1 fund opened new TriSalus Life Sciences Warrant positions in Q1 2025 and 3 closed out, a net change of -2 holders.
- The largest TriSalus Life Sciences Warrant buyer in Q1 2025 was Bank of America, an estimated $227 added.
- The largest TriSalus Life Sciences Warrant seller in Q1 2025 was HRT Financial, an estimated $23K sold.
Based on aggregated 13F filings for Q1 2025.